News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on ProMedicus.
RELATED STOCKHEAD STORIES
News
ASX Earnings Wrap: Reckon jumps 13pc; Pro Medicus keeps delivering, up almost 40pc this year
Health & Biotech
ScoPo’s Powerplays: Mesoblast sinks Health sector, and how to live 24 years longer
Health & Biotech
ASX Health Stocks: Pro Medicus nabs $24m, 7-year deal with world renowned cancer hospital
Health & Biotech
ScoPo’s (actually Iain’s) Powerplays: ASX health stocks fall as CSL faces FX headwinds
Health & Biotech
4D Medical’s technology disrupts century-old procedures AND makes over 90pc profit margin
Experts
CRITERION: This ASX biotech is the sole dedicated player in a new $420 billion market
Director Trades
ASX Director Trades: A game of give-and-take as Gerry Harvey buys up $80m while Pro Medicus co-founders sell off $64m
Health & Biotech
Why growth is a positive for the ASX medical imaging sector
News
Which ASX micro caps have potential to grow exponentially through big partnership deals?
Health & Biotech
ScoPo’s Powerplays: ASX health stocks drop 0.3% but reporting season gives cause for optimism
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall but cap raises show money flowing into sector
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rise, Mach 7 lands largest contract and posts record quarter
News
ASX Large Caps: Another good week for the ASX, but Big Tech’s misses pose concern
News
ASX Large Caps: Shares end the week up 1.6pc ahead of lunar new year; Pilbara jumps 13pc
Health & Biotech
ScoPo’s Powerplays: ASX health stocks sprout 4.6%, as Volpara soars on first positive cash flow
Health & Biotech
Here’s why Morningstar reckons the ASX healthcare sector is on road to recovery
Health & Biotech